FDA dropped the amended Part 820 Rule on Feb. 2. Evan Phelps suggests medical device manufacturers look at their processes, procedures, and documentation and prepare to comply in the next two years.
5185 MacArthur Blvd NW
Suite 230
Washington, D.C. 20016
PH:202.496.4966
515 South Flower Street
18th Floor
Los Angeles, CA 90071
PH:213.933.2330
The content in the Amin Wasserman Gurnani web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Wasserman Gurnani or as the rendering of legal advice for any specific matter.
